002332 Zhejiang Xianju Pharmaceutical
- 12.64
- +0.05+0.40%
Zhejiang Xianju Pharmaceutical News
Zhejiang Xianju Pharmaceutical: Xianju Pharmaceutical: 2023 Annual Equity Distribution Implementation Notice
Xianju Pharmaceutical: Announcement on the 2023 Profit Distribution Plan
Xianju Pharmaceutical: Xianju Pharmaceutical: 2022 Annual Equity Distribution Implementation Notice
Xianju Pharmaceutical: Announcement on the holding subsidiary's intention to publicly list and transfer 14.6% of the shares of the participating companies
Xianju Pharmaceutical: Announcement on the progress of the public listing and transfer of 11% of the shares of the holding subsidiary Xianju Cuize
Xianju Pharmaceutical: An indicative announcement on the listing and circulation of non-public restricted shares
Xianju Pharmaceutical: Independent Directors' Independent Opinions on Proposed Disclosure of Shareholding Subsidiaries' Shares
Xianju Pharmaceutical: Announcement on proposed public listing and transfer of 61.2% of the shares of the holding subsidiary Haisheng Pharmaceutical
Xianju Pharmaceutical: Announcement on the Chairman and General Manager's Increase in the Company's Shares
Xianju Pharmaceutical: Xianju Pharmaceutical: 2020 Annual Equity Distribution Implementation Notice
Xianju Pharmaceutical: An indicative announcement on the listing and circulation of non-public restricted shares
Xianju Pharmaceutical: Issuance Report and Listing Announcement for the Non-public Offering of A-Shares
Xianju Pharmaceutical: Issuance Report and Listing Announcement Summary for the Non-public Offering of A-Shares
Xianju Pharmaceutical: Announcement on the application for the non-public offering of shares approved by the China Securities Regulatory Commission
Xianju Pharmaceutical: Notice on the application for non-public offering of shares approved by the Issuance Review Committee of the China Securities Regulatory Commission
Xianju Pharmaceutical: Announcement on Response to the Notice of Preparation for the Non-public Issuance of Shares Development and Review Committee Meeting
Xianju Pharmaceutical: Response to feedback on application documents for the non-public offering of shares
Xianju Pharmaceutical: Notice on Receiving the “China Securities Regulatory Commission Administrative Licensing Project Review Once Feedback Notice”
Xianju Pharmaceutical: Announcement on the application for the non-public offering of shares accepted by the China Securities Regulatory Commission
Xianju Pharmaceutical: Announcement on the non-public offering of shares approved by the state-owned funding department
Analysis
Price Target
No Data
No Data